The cardiac fibroblast: Origin, identity and role in homeostasis and disease

Differentiation

Volumn 92, Issue 3, 2016, Pages 93-101

  Furtado, Milena B ^a,b   Costa, Mauro W ^a,b   Rosenthal, Nadia A ^a,b,c  

^a JACKSON LABORATORY   (United States)

^b MONASH UNIVERSITY   (Australia)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cardiac fibroblast; Disease; Embryological origin; Homeostasis; Molecular identity

Indexed keywords

ADULT; CARDIAC MUSCLE CELL; CARDIOVASCULAR FUNCTION; CELL FUNCTION; CELL POPULATION; CELLS; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EMBRYO DEVELOPMENT; FIBROCYTE; HEART DEVELOPMENT; HEART DISEASE; HEART FIBROBLAST; HOMEOSTASIS; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CYTOLOGY; FIBROBLAST; GROWTH, DEVELOPMENT AND AGING; HEART; MESENCHYMAL STROMA CELL; PHYSIOLOGY; STEM CELL;

ANIMALS; FIBROBLASTS; HEART; HOMEOSTASIS; HUMANS; MESENCHYMAL STROMAL CELLS; STEM CELLS;

EID: 84994010489     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2016.06.004     Document Type: Review

References (94)

1. Acharya, A., Baek, S.T., Huang, G., Eskiocak, B., Goetsch, S., Sung, C.Y., Banfi, S., Sauer, M.F., Olsen, G.S., Duffield, J.S., Olson, E.N., Tallquist, M.D., The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 139 (2012), 2139–2149.
2. Ahuja, P., Sdek, P., MacLellan, W.R., Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87 (2007), 521–544.
3. Ali, S.R., Ranjbarvaziri, S., Talkhabi, M., Zhao, P., Subat, A., Hojjat, A., Kamran, P., Muller, A.M., Volz, K.S., Tang, Z., Red-Horse, K., Ardehali, R., Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ. Res. 115 (2014), 625–635.
4. Asakura, A., Rudnicki, M.A., Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp. Hematol. 30 (2002), 1339–1345.
5. Baudino, T.A., Carver, W., Giles, W., Borg, T.K., Cardiac fibroblasts: friend or foe?. Am. J. Physiol. Heart Circ. Physiol. 291 (2006), H1015–H1026.
6. Baum, J., Duffy, H.S., Fibroblasts and myofibroblasts: what are we talking about?. J. Cardiovasc. Pharmacol. 57 (2011), 376–379.
7. Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B., Anversa, P., Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003), 763–776.
8. Bergmann, O., Bhardwaj, R.D., Bernard, S., Zdunek, S., Barnabe-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B.A., Druid, H., Jovinge, S., Frisen, J., Evidence for cardiomyocyte renewal in humans. Science 324 (2009), 98–102.
9. Bolli, R., Chugh, A.R., D'Amario, D., Loughran, J.H., Stoddard, M.F., Ikram, S., Beache, G.M., Wagner, S.G., Leri, A., Hosoda, T., Sanada, F., Elmore, J.B., Goichberg, P., Cappetta, D., Solankhi, N.K., Fahsah, I., Rokosh, D.G., Slaughter, M.S., Kajstura, J., Anversa, P., Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378 (2011), 1847–1857.
10. Bouveret, R., Waardenberg, A.J., Schonrock, N., Ramialison, M., Doan, T., de Jong, D., Bondue, A., Kaur, G., Mohamed, S., Fonoudi, H., Chen, C.M., Wouters, M.A., Bhattacharya, S., Plachta, N., Dunwoodie, S.L., Chapman, G., Blanpain, C., Harvey, R.P., NKX2-5 mutations causative for congenital heart disease retain functionality and are directed to hundreds of targets. eLife, 2015, 4.
11. Burstein, B., Libby, E., Calderone, A., Nattel, S., Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 117 (2008), 1630–1641.
12. Cai, C.L., Martin, J.C., Sun, Y., Cui, L., Wang, L., Ouyang, K., Yang, L., Bu, L., Liang, X., Zhang, X., Stallcup, W.B., Denton, C.P., McCulloch, A., Chen, J., Evans, S.M., A myocardial lineage derives from Tbx18 epicardial cells. Nature 454 (2008), 104–108.
13. Cai, X., Zhang, W., Hu, J., Zhang, L., Sultana, N., Wu, B., Cai, W., Zhou, B., Cai, C.L., Tbx20 acts upstream of Wnt signaling to regulate endocardial cushion formation and valve remodeling during mouse cardiogenesis. Development 140 (2013), 3176–3187.
14. Camelliti, P., Borg, T.K., Kohl, P., Structural and functional characterisation of cardiac fibroblasts. Cardiovasc. Res. 65 (2005), 40–51.
15. Chaudhry, H.W., Dashoush, N.H., Tang, H., Zhang, L., Wang, X., Wu, E.X., Wolgemuth, D.J., Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J. Biol. Chem. 279 (2004), 35858–35866.
16. Chong, J.J., Reinecke, H., Iwata, M., Torok-Storb, B., Stempien-Otero, A., Murry, C.E., Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart. Stem Cells Dev. 22 (2013), 1932–1943.
17. Chong, J.J., Chandrakanthan, V., Xaymardan, M., Asli, N.S., Li, J., Ahmed, I., Heffernan, C., Menon, M.K., Scarlett, C.J., Rashidianfar, A., Biben, C., Zoellner, H., Colvin, E.K., Pimanda, J.E., Biankin, A.V., Zhou, B., Pu, W.T., Prall, O.W., Harvey, R.P., Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 9 (2011), 527–540.
18. Christoffels, V.M., Moorman, A.F., Development of the cardiac conduction system: why are some regions of the heart more arrhythmogenic than others?. Circ. Arrhythm. Electrophysiol. 2 (2009), 195–207.
19. Curnow, S.J., Fairclough, M., Schmutz, C., Kissane, S., Denniston, A.K., Nash, K., Buckley, C.D., Lord, J.M., Salmon, M., Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum. PloS One, 5, 2010, e9730.
20. D'Uva, G., Aharonov, A., Lauriola, M., Kain, D., Yahalom-Ronen, Y., Carvalho, S., Weisinger, K., Bassat, E., Rajchman, D., Yifa, O., Lysenko, M., Konfino, T., Hegesh, J., Brenner, O., Neeman, M., Yarden, Y., Leor, J., Sarig, R., Harvey, R.P., Tzahor, E., ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. Nat. Cell Biol. 17 (2015), 627–638.
21. Del Re, D.P., Yang, Y., Nakano, N., Cho, J., Zhai, P., Yamamoto, T., Zhang, N., Yabuta, N., Nojima, H., Pan, D., Sadoshima, J., Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury. J. Biol. Chem. 288 (2013), 3977–3988.
22. Diez, J., Mechanisms of cardiac fibrosis in hypertension. J. Clin. Hypertens. 9 (2007), 546–550.
23. Epelman, S., Lavine, K.J., Beaudin, A.E., Sojka, D.K., Carrero, J.A., Calderon, B., Brija, T., Gautier, E.L., Ivanov, S., Satpathy, A.T., Schilling, J.D., Schwendener, R., Sergin, I., Razani, B., Forsberg, E.C., Yokoyama, W.M., Unanue, E.R., Colonna, M., Randolph, G.J., Mann, D.L., Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40 (2014), 91–104.
24. Fan, D., Takawale, A., Lee, J., Kassiri, Z., Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair, 5, 2012, 15.
25. Furtado, M.B., Nim, H.T., Boyd, S.E., Rosenthal, N.A., View from the heart: cardiac fibroblasts in development, scarring and regeneration. Development 143 (2016), 387–397.
26. Furtado, M.B., Nim, H.T., Gould, J.A., Costa, M.W., Rosenthal, N.A., Boyd, S.E., Microarray profiling to analyse adult cardiac fibroblast identity. Genom. Data 2 (2014), 345–350.
27. Furtado, M.B., Costa, M.W., Pranoto, E.A., Salimova, E., Pinto, A.R., Lam, N.T., Park, A., Snider, P., Chandran, A., Harvey, R.P., Boyd, R., Conway, S.J., Pearson, J., Kaye, D.M., Rosenthal, N.A., Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. Circ. Res. 114 (2014), 1422–1434.
28. Garg, V., Kathiriya, I.S., Barnes, R., Schluterman, M.K., King, I.N., Butler, C.A., Rothrock, C.R., Eapen, R.S., Hirayama-Yamada, K., Joo, K., Matsuoka, R., Cohen, J.C., Srivastava, D., GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424 (2003), 443–447.
29. Granados-Riveron, J.T., Pope, M., Bu'lock, F.A., Thornborough, C., Eason, J., Setchfield, K., Ketley, A., Kirk, E.P., Fatkin, D., Feneley, M.P., Harvey, R.P., Brook, J.D., Combined mutation screening of NKX2-5, GATA4, and TBX5 in congenital heart disease: multiple heterozygosity and novel mutations. Congenit. Heart Dis. 7 (2012), 151–159.
30. Gustafsson, E., Brakebusch, C., Hietanen, K., Fassler, R., Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J. Cell Sci. 114 (2001), 671–676.
31. Harvey, R.P., Lai, D., Elliott, D., Biben, C., Solloway, M., Prall, O., Stennard, F., Schindeler, A., Groves, N., Lavulo, L., Hyun, C., Yeoh, T., Costa, M., Furtado, M., Kirk, E., Homeodomain factor Nkx2-5 in heart development and disease. Cold Spring Harb. Symp. Quant. Biol. 67 (2002), 107–114.
32. Hassink, R.J., Pasumarthi, K.B., Nakajima, H., Rubart, M., Soonpaa, M.H., de la Riviere, A.B., Doevendans, P.A., Field, L.J., Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc. Res. 78 (2008), 18–25.
33. Hayashi, M., Ninomiya, Y., Hayashi, K., Linsenmayer, T.F., Olsen, B.R., Trelstad, R.L., Secretion of collagen types I and II by epithelial and endothelial cells in the developing chick cornea demonstrated by in situ hybridization and immunohistochemistry. Development 103 (1988), 27–36.
34. Hildreth, V., Webb, S., Bradshaw, L., Brown, N.A., Anderson, R.H., Henderson, D.J., Cells migrating from the neural crest contribute to the innervation of the venous pole of the heart. J. Anat. 212 (2008), 1–11.
35. Ieda, M., Tsuchihashi, T., Ivey, K.N., Ross, R.S., Hong, T.T., Shaw, R.M., Srivastava, D., Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev. Cell 16 (2009), 233–244.
36. Kajstura, J., Gurusamy, N., Ogorek, B., Goichberg, P., Clavo-Rondon, C., Hosoda, T., D'Amario, D., Bardelli, S., Beltrami, A.P., Cesselli, D., Bussani, R., del Monte, F., Quaini, F., Rota, M., Beltrami, C.A., Buchholz, B.A., Leri, A., Anversa, P., Myocyte turnover in the aging human heart. Circ. Res. 107 (2010), 1374–1386.
37. Kensah, G., Roa Lara, A., Dahlmann, J., Zweigerdt, R., Schwanke, K., Hegermann, J., Skvorc, D., Gawol, A., Azizian, A., Wagner, S., Maier, L.S., Krause, A., Drager, G., Ochs, M., Haverich, A., Gruh, I., Martin, U., Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur. Heart J. 34 (2012), 1134–1146.
38. Kikuchi, K., Advances in understanding the mechanism of zebrafish heart regeneration. Stem Cell Res. 13 (2014), 542–555.
39. Kirk, E.P., Sunde, M., Costa, M.W., Rankin, S.A., Wolstein, O., Castro, M.L., Butler, T.L., Hyun, C., Guo, G., Otway, R., Mackay, J.P., Waddell, L.B., Cole, A.D., Hayward, C., Keogh, A., Macdonald, P., Griffiths, L., Fatkin, D., Sholler, G.F., Zorn, A.M., Feneley, M.P., Winlaw, D.S., Harvey, R.P., Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am. J. Hum. Genet. 81 (2007), 280–291.
40. Kisanuki, Y.Y., Hammer, R.E., Miyazaki, J., Williams, S.C., Richardson, J.A., Yanagisawa, M., Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230 (2001), 230–242.
41. Krenning, G., Zeisberg, E.M., Kalluri, R., The origin of fibroblasts and mechanism of cardiac fibrosis. J. Cell. Physiol. 225 (2010), 631–637.
42. Kubin, T., Poling, J., Kostin, S., Gajawada, P., Hein, S., Rees, W., Wietelmann, A., Tanaka, M., Lorchner, H., Schimanski, S., Szibor, M., Warnecke, H., Braun, T., Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell 9 (2011), 420–432.
43. Langness, U., Udenfriend, S., Collagen biosynthesis in nonfibroblastic cell lines. Proc. Natl. Acad. Sci. USA 71 (1974), 50–51.
44. Laugwitz, K.L., Moretti, A., Lam, J., Gruber, P., Chen, Y., Woodard, S., Lin, L.Z., Cai, C.L., Lu, M.M., Reth, M., Platoshyn, O., Yuan, J.X., Evans, S., Chien, K.R., Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433 (2005), 647–653.
45. Li, F., Wang, X., Capasso, J.M., Gerdes, A.M., Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 28 (1996), 1737–1746.
46. Li, M., Riddle, S.R., Frid, M.G., El Kasmi, K.C., McKinsey, T.A., Sokol, R.J., Strassheim, D., Meyrick, B., Yeager, M.E., Flockton, A.R., McKeon, B.A., Lemon, D.D., Horn, T.R., Anwar, A., Barajas, C., Stenmark, K.R., Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension. J. Immunol. 187 (2011), 2711–2722.
47. Liao, H.S., Kang, P.M., Nagashima, H., Yamasaki, N., Usheva, A., Ding, B., Lorell, B.H., Izumo, S., Cardiac-specific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes. Circ. Res. 88 (2001), 443–450.
48. Lin, Z., von Gise, A., Zhou, P., Gu, F., Ma, Q., Jiang, J., Yau, A.L., Buck, J.N., Gouin, K.A., van Gorp, P.R., Zhou, B., Chen, J., Seidman, J.G., Wang, D.Z., Pu, W.T., Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model. Circ. Res. 115 (2014), 354–363.
49. Messina, E., De Angelis, L., Frati, G., Morrone, S., Chimenti, S., Fiordaliso, F., Salio, M., Battaglia, M., Latronico, M.V., Coletta, M., Vivarelli, E., Frati, L., Cossu, G., Giacomello, A., Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95 (2004), 911–921.
50. Misra, C., Sachan, N., McNally, C.R., Koenig, S.N., Nichols, H.A., Guggilam, A., Lucchesi, P.A., Pu, W.T., Srivastava, D., Garg, V., Congenital heart disease-causing Gata4 mutation displays functional deficits in vivo. PLoS Genet., 8, 2012, e1002690.
51. del Monte, G., Casanova, J.C., Guadix, J.A., MacGrogan, D., Burch, J.B., Perez-Pomares, J.M., de la Pompa, J.L., Differential Notch signaling in the epicardium is required for cardiac inflow development and coronary vessel morphogenesis. Circ. Res. 108 (2011), 824–836.
52. Moore-Morris, T., Guimaraes-Camboa, N., Banerjee, I., Zambon, A.C., Kisseleva, T., Velayoudon, A., Stallcup, W.B., Gu, Y., Dalton, N.D., Cedenilla, M., Gomez-Amaro, R., Zhou, B., Brenner, D.A., Peterson, K.L., Chen, J., Evans, S.M., Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J. Clin. Investig. 124 (2014), 2921–2934.
53. Moskowitz, I.P., Wang, J., Peterson, M.A., Pu, W.T., Mackinnon, A.C., Oxburgh, L., Chu, G.C., Sarkar, M., Berul, C., Smoot, L., Robertson, E.J., Schwartz, R., Seidman, J.G., Seidman, C.E., Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. [corrected]. Proc. Natl. Acad. Sci. USA 108 (2011), 4006–4011.
54. Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., Das, S.R., de Ferranti, S., Despres, J.P., Fullerton, H.J., Howard, V.J., Huffman, M.D., Isasi, C.R., Jimenez, M.C., Judd, S.E., Kissela, B.M., Lichtman, J.H., Lisabeth, L.D., Liu, S., Mackey, R.H., Magid, D.J., McGuire, D.K., Mohler, E.R. 3rd, Moy, C.S., Muntner, P., Mussolino, M.E., Nasir, K., Neumar, R.W., Nichol, G., Palaniappan, L., Pandey, D.K., Reeves, M.J., Rodriguez, C.J., Rosamond, W., Sorlie, P.D., Stein, J., Towfighi, A., Turan, T.N., Virani, S.S., Woo, D., Yeh, R.W., Turner, M.B., Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133 (2015), e38–e360.
55. Muir, H., The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 17 (1995), 1039–1048.
56. Oh, H., Bradfute, S.B., Gallardo, T.D., Nakamura, T., Gaussin, V., Mishina, Y., Pocius, J., Michael, L.H., Behringer, R.R., Garry, D.J., Entman, M.L., Schneider, M.D., Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA 100 (2003), 12313–12318.
57. Pasumarthi, K.B., Nakajima, H., Nakajima, H.O., Soonpaa, M.H., Field, L.J., Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ. Res. 96 (2005), 110–118.
58. Peng, X., Mathai, S.K., Murray, L.A., Russell, T., Reilkoff, R., Chen, Q., Gulati, M., Elias, J.A., Bucala, R., Gan, Y., Herzog, E.L., Local apoptosis promotes collagen production by monocyte-derived cells in transforming growth factor beta1-induced lung fibrosis. Fibrogenesis Tissue Repair, 4, 2011, 12.
59. Piek, A., de Boer, R.A., Sillje, H.H., The fibrosis-cell death axis in heart failure. Heart Fail Rev. 21 (2016), 199–211.
60. Pilling, D., Fan, T., Huang, D., Kaul, B., Gomer, R.H., Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PloS One, 4, 2009, e7475.
61. Pinto, A.R., Paolicelli, R., Salimova, E., Gospocic, J., Slonimsky, E., Bilbao-Cortes, D., Godwin, J.W., Rosenthal, N.A., An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PloS One, 7, 2012, e36814.
62. Pinto, A.R., Ilinykh, A., Ivey, M.J., Kuwabara, J.T., D'Antoni, M., Debuque, R.J., Chandran, A., Wang, L., Arora, K., Rosenthal, N., Tallquist, M.D., Revisiting cardiac cellular composition. Circ. Res. 118 (2016), 400–409.
63. Polizzotti, B.D., Ganapathy, B., Walsh, S., Choudhury, S., Ammanamanchi, N., Bennett, D.G., Dos Remedios, C.G., Haubner, B.J., Penninger, J.M., Kuhn, B., Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window. Sci. Transl. Med., 7, 2015 281ra245.
64. Posch, M.G., Gramlich, M., Sunde, M., Schmitt, K.R., Lee, S.H., Richter, S., Kersten, A., Perrot, A., Panek, A.N., Al Khatib, I.H., Nemer, G., Megarbane, A., Dietz, R., Stiller, B., Berger, F., Harvey, R.P., Ozcelik, C., A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J. Med. Genet. 47 (2010), 230–235.
65. Qiao, Y., Wanyan, H., Xing, Q., Xie, W., Pang, S., Shan, J., Yan, B., Genetic analysis of the TBX20 gene promoter region in patients with ventricular septal defects. Gene 500 (2012), 28–31.
66. Rizvi, F., Siddiqui, R., DeFranco, A., Emelyanova, L., Holmuhamedov, A., Ross, G., Holmuhamedov, E., Kress, D., Tajik, A.J., Jahangir, A., Differential responsiveness of human atrial and ventricular fibroblasts to serum-induced proliferation and its inhibition by simvastatin, American College of Cardiology - Heart Failure and Cardiomyopathies. J. Am. Coll. Cardiol., 2016 p. poster 1493.
67. Rodero, M.P., Legrand, J.M., Bou-Gharios, G., Khosrotehrani, K., Wound-associated macrophages control collagen 1alpha2 transcription during the early stages of skin wound healing. Exp. Dermatol. 22 (2013), 143–145.
68. Rog-Zielinska, E.A., Norris, R.A., Kohl, P., Markwald, R., The living scar - cardiac fibroblasts and the injured heart. Trends Mol. Med. 22 (2016), 99–114.
69. Ruiz-Villalba, A., Simon, A.M., Pogontke, C., Castillo, M.I., Abizanda, G., Pelacho, B., Sanchez-Dominguez, R., Segovia, J.C., Prosper, F., Perez-Pomares, J.M., 2015. Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar. J. Am. Coll. Cardiol., vol. 65, pp. 2057–2066.
70. Schlesinger, J., Schueler, M., Grunert, M., Fischer, J.J., Zhang, Q., Krueger, T., Lange, M., Tonjes, M., Dunkel, I., Sperling, S.R., The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genet., 7, 2011, e1001313.
71. Schnoor, M., Cullen, P., Lorkowski, J., Stolle, K., Robenek, H., Troyer, D., Rauterberg, J., Lorkowski, S., Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity. J. Immunol. 180 (2008), 5707–5719.
72. Shapiro, S.D., Ranjan, A.K., Kawase, Y., Cheng, R.K., Kara, R.J., Bhattacharya, R., Guzman-Martinez, G., Sanz, J., Garcia, M.J., Chaudhry, H.W., Cyclin A2 induces cardiac regeneration after myocardial infarction through cytokinesis of adult cardiomyocytes. Sci. Transl. Med., 6, 2014 224ra227.
73. Smart, N., Bollini, S., Dube, K.N., Vieira, J.M., Zhou, B., Davidson, S., Yellon, D., Riegler, J., Price, A.N., Lythgoe, M.F., Pu, W.T., Riley, P.R., De novo cardiomyocytes from within the activated adult heart after injury. Nature 474 (2011), 640–644.
74. Snider, P., Simmons, O., Wang, J., Hoang, C.Q., Conway, S.J., Ectopic noggin in a population of Nfatc1 lineage endocardial progenitors induces embryonic lethality. J. Cardiovasc. Dev. Dis. 1 (2014), 214–236.
75. Soonpaa, M.H., Koh, G.Y., Pajak, L., Jing, S., Wang, H., Franklin, M.T., Kim, K.K., Field, L.J., Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J. Clin. Investig. 99 (1997), 2644–2654.
76. Stempien-Otero, A., Kim, D.H., Davis, J., Molecular networks underlying myofibroblast fate and fibrosis. J. Mol. Cell Cardiol., 2016.
77. Takeda, N., Manabe, I., Uchino, Y., Eguchi, K., Matsumoto, S., Nishimura, S., Shindo, T., Sano, M., Otsu, K., Snider, P., Conway, S.J., Nagai, R., Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J. Clin. Investig. 120 (2010), 254–265.
78. Travers, J.G., Kamal, F.A., Robbins, J., Yutzey, K.E., Blaxall, B.C., Cardiac fibrosis: the fibroblast awakens. Circ. Res. 118 (2016), 1021–1040.
79. Turner, N.A.S., The Cardiac Fibroblast. 1st ed., 2011, Research Signpost, Kerala, India.
80. Vaage, J., Lindblad, W.J., Production of collagen type I by mouse peritoneal macrophages. J. Leukoc. Biol. 48 (1990), 274–280.
81. Vaage, J., Harlos, J.P., Collagen production by macrophages in tumour encapsulation and dormancy. Br. J. Cancer 63 (1991), 758–762.
82. van Berlo, J.H., Kanisicak, O., Maillet, M., Vagnozzi, R.J., Karch, J., Lin, S.C., Middleton, R.C., Marban, E., Molkentin, J.D., c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509 (2014), 337–341.
83. Vasquez, C., Benamer, N., Morley, G.E., The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts. J. Cardiovasc. Pharmacol. 57 (2011), 380–388.
84. von Gise, A., Pu, W.T., Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ. Res. 110 (2012), 1628–1645.
85. von Gise, A., Lin, Z., Schlegelmilch, K., Honor, L.B., Pan, G.M., Buck, J.N., Ma, Q., Ishiwata, T., Zhou, B., Camargo, F.D., Pu, W.T., YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc. Natl. Acad. Sci. USA 109 (2012), 2394–2399.
86. Weber, K.T., Sun, Y., Bhattacharya, S.K., Ahokas, R.A., Gerling, I.C., Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nature reviews. Cardiology 10 (2013), 15–26.
87. Wessels, A., van den Hoff, M.J., Adamo, R.F., Phelps, A.L., Lockhart, M.M., Sauls, K., Briggs, L.E., Norris, R.A., van Wijk, B., Perez-Pomares, J.M., Dettman, R.W., Burch, J.B., Epicardially derived fibroblasts preferentially contribute to the parietal leaflets of the atrioventricular valves in the murine heart. Dev. Biol. 366 (2012), 111–124.
88. Woo, Y.J., Panlilio, C.M., Cheng, R.K., Liao, G.P., Atluri, P., Hsu, V.M., Cohen, J.E., Chaudhry, H.W., Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation 114 (2006), I206–I213.
89. Wynn, T.A., Cellular and molecular mechanisms of fibrosis. J. Pathol. 214 (2008), 199–210.
90. Xin, M., Kim, Y., Sutherland, L.B., Qi, X., McAnally, J., Schwartz, R.J., Richardson, J.A., Bassel-Duby, R., Olson, E.N., Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal., 4, 2011, ra70.
91. Xin, M., Kim, Y., Sutherland, L.B., Murakami, M., Qi, X., McAnally, J., Porrello, E.R., Mahmoud, A.I., Tan, W., Shelton, J.M., Richardson, J.A., Sadek, H.A., Bassel-Duby, R., Olson, E.N., Hippo pathway effector Yap promotes cardiac regeneration. Proc. Natl. Acad. Sci. USA 110 (2013), 13839–13844.
92. Zeisberg, E.M., Tarnavski, O., Zeisberg, M., Dorfman, A.L., McMullen, J.R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W.T., Roberts, A.B., Neilson, E.G., Sayegh, M.H., Izumo, S., Kalluri, R., Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13 (2007), 952–961.
93. Zhou, B., Pu, W.T., Epicardial epithelial-to-mesenchymal transition in injured heart. J. Cell Mol. Med. 15 (2011), 2781–2783.
94. Zhou, B., Honor, L.B., Ma, Q., Oh, J.H., Lin, R.Z., Melero-Martin, J.M., von Gise, A., Zhou, P., Hu, T., He, L., Wu, K.H., Zhang, H., Zhang, Y., Pu, W.T., Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes. J. Mol. Cell. Cardiol. 52 (2012), 43–47.